Vasculopathy in type 2 diabetes mellitus: Role of specific angiogenic modulators

Journal of Physiology and Biochemistry

Volumn 67, Issue 3, 2011, Pages 339-349

  Hamed, Enas A ^a   Zakary, Madeha M ^a   Abdelal, Reffat M ^b   Abdel Moneim, Effat M ^a  

^a ASSIUT UNIVERSITY   (Egypt)

^b Assiut University Faculty of Medicine   (Egypt)

Author keywords

Advanced glycosylation end products; Angiogenesis; Basic fibroblast growth factor; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOGENIC PROTEIN; FIBROBLAST GROWTH FACTOR 2; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; HYALURONIC ACID; LIPID PEROXIDE; THYMIDINE PHOSPHORYLASE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MICROVASCULATURE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); NON INSULIN DEPENDENT DIABETES MELLITUS; NONPARAMETRIC TEST; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; ANALYSIS OF VARIANCE; ANGIOGENIC PROTEINS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FIBROBLAST GROWTH FACTOR 2; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYALURONIC ACID; LIPID PEROXIDES; MALE; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; STATISTICS, NONPARAMETRIC; THYMIDINE PHOSPHORYLASE;

EID: 84856371666     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-011-0080-8     Document Type: Article

References (59)

1. Ahmed N, Thornalley PJ (2007) Advanced glycation end products: what is their relevance to diabetic complications. Diab Obes Metab 9:233-245 (Pubitemid 46502041)
2. Babaei S, Teichert-Kuliszewska K, Monge JC, Mohamed F, Bendeck MP, Stewart DJ (1998) Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res 82:1007-1015 (Pubitemid 28225941)
3. Bach MH, Sadoun E, Reed MJ (2005) Defects in activation of nitric oxide synthases occur during delayed angiogenesis in aging. Mech Ageing Dev 126:467-473 (Pubitemid 40269290)
4. Barrett AJ (1970) Cathepsin D. Purification of isoenzymes from human and chicken liver. Biochem J 117(3):601-607
5. Bejma J, Ji LL (1999) Aging and acute exercise enhance free radical generation in rat skeletal muscle. J Appl Physiol 87(1):465-470 (Pubitemid 29330715)
6. Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M, Liaudet-Coopman E (2002) Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 21(38):5951-5955 (Pubitemid 35007248)
7. Briozzo P, Badet J, Capony F, Pieri I, Montcourrier P, Barritault D, Rochefort H (1991) MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res 194(2):252-259 (Pubitemid 121006277)
8. Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R (2000) Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res 60(22):6298-6302
9. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865):813-820
10. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625
11. Calhau C, Santos A (2009) Oxidative stress in the metabolic syndrome. In: Soares R, Costa C (eds) Oxidative stress, inflammation and angiogenesis in metabolic syndrome. Springer, The Netherlands, pp 33-63
12. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
13. de Bruin M, Temmink OH, Hoekman K, Pinedo HM, Peters GJ (2006) Role of platelet derived endothelial cell growth factor/thymidine phosphorylase in health and disease. Cancer Ther 4:99-124
14. Detillieux KA, Sheikh F, Kardami E, Cattini PA (2003) Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 57:8-19 (Pubitemid 36009431)
15. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 2:70-77
16. El-Remessy A, Abou-Mohamed G, Caldwell RW, Caldwell RB (2003) High glucose increases tyrosine nitration and superoxide anion formation in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest Ophthalmol Vis Sci 44:3135- 3143
17. Fukui T, Noma T, Mizushige K, Aki Y, Kimura S, Abe Y (2000) Dietary troglitazone decreases oxidative stress in early stage type II diabetic rats. Life Sci 66:2043-2049 (Pubitemid 30217797)
18. Grau A, Codony R, Rafecas M, Barroeta AC, Guardiola F (2000) Lipid hydroperoxide determination in dark chicken meat through a ferrous oxidation-xylenol orange method. J Agric Food Chem 48(9):4136-4143
19. Greiling H (1961) A new colorimetric method for enzymatic determination of hyaluronic acid. Z Rheumaforsch 20:298-302
20. Hameed A, Malik S, Sharif FR, Ahmed N, Nurjis F, Ali S, Qureshi JA (2002) Diabetic complications: influence of age, sex, family history, duration, glycemic control and obesity. Online J Biol Sci 2(10):710 -714
21. Hu GF (1998) Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem 69(3):326-335
22. Koga K, Yamagishi S, Okamoto T, Inagaki Y, Amano S, Takeuchi M, Makita Z (2002) Serum levels of glucose-derived advanced glycation end products are associated with the severity of diabetic retinopathy in type 2 diabetic patients without renal dysfunction. Int J Clin Pharmacol Res 22(1):13 -17
23. Larke RP, Froese GJ, Devine RD, Petruk MW (1988) Comprehensive seroepidemiologic study of hepatitis B virus infection in the Northwest Territories of Canada. Arct Med Res 47(1):711-713
24. Maritim AC, Sanders RA, Watkins JB III (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17:24-38 (Pubitemid 36410972)
25. Martin A, Komada MR, Sane DC (2003) Abnormal angiogenesis in diabetes mellitus. Med Res Rev 23:117-145 (Pubitemid 36241095)
26. McAuslan BR, Reilly W (1980) Endothelial cell phagokinesis in response to specific metal ions. Exp Cell Res 130(1):147-157 (Pubitemid 11189744)
27. Misra HP, Fridovich I (1972) The generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem 247(21):6960-6962
28. Murphy JF, Lennon F, Steele C, Kelleher D, Fitzgerald D, Long AC (2005) Engagement of CD44 modulates cyclooxygenase induction, VEGF generation and proliferation in human vascular endothelial cells. FASEB J 19:446-448 (Pubitemid 40316545)
29. Nagai Y (1995) Functional roles of gangliosides in biosignaling. Behav Brain Res 66:99-104
30. Nayeemunnisa (2008) Proteolytic activity in the brain of alloxan diabetic rats: presence of a proteolytic activator in the cerebral extract. Int J Diabetes Dev Ctries 28(3):83-85
31. Ohshiro Y, Takasu N (2006) Molecular mechanism of diabetic nephropathy. Nippon Rinsho 64:997-1003
32. Pardue EL, Ibrahim S, Ramamurthi A (2008) Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering. Organogenesis 4(4):203-214
33. Plucinsky MC, Prorok JJ, Alhadeff JA (1986) Variant serum beta-hexosaminidase as a biochemical marker of malignancy. Cancer 58(7):1484-1487 (Pubitemid 16016833)
34. Poggioli S, Hilaire B, Friguet B (2002) Age-related increase of proteins glycation in peripheral blood lymphocytes is restricted to preferential target proteins. Exp Geront 37:1207-1215 (Pubitemid 35418278)
35. Roberts DD, Isenberg JS, Ridnour LA, Wink DA (2007) Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis. Clin Cancer Res 13(3):795-798 (Pubitemid 46340351)
36. Saharinen P, Alitalo K (2003) Double target for tumor mass destruction. J Clin Invest 111:1277-1280 (Pubitemid 36554696)
37. Sakuaba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S (2002) Reduced β-cell mass and expression of oxidative stress related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 45:85-96 (Pubitemid 34118546)
38. Scocca JJ (1978) Pyrimidine nucleoside phosphorylase from Haemophilus influenzae. Meth Enzymol 51:432-437
39. Skrzydlewska E, Sulkowska M, Wincewicz A, Koda M, Sulkowski S (2005) Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer. World J Gastroenterol 11(27):4225-4229 (Pubitemid 41086876)
40. Slavin J (1995) Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int 19:431-444
41. Tanihara H, Inatani M, Honda Y (1997) Growth factors and their receptors in the retina and pigmented epithelium. In: Osborne N, Chader G (eds) Progress in retinal and eye research. Pergamon, Oxford, pp 271-301 (Pubitemid 27060194)
42. Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A (2003) Quantitative screening of advanced glycation end-products in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 375:581-592 (Pubitemid 37433506)
43. van Bezooijen RL, Que I, Ederveen AG, Kloosterboer HJ, Papapoulos SE, Lowik CW (1998) Plasma nitrate+nitrite level are regulated by ovarian steroids but do not correlate with trabecular bone mineral density in rats. J Endocrinol 159:27-34 (Pubitemid 28459263)
44. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinses - structure, function, and biochemistry. Circ Res 92:827-839 (Pubitemid 36542523)
45. Walter RM Jr, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW, Keen CL (1991) Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diab Care 14(11):1050-1056
46. Wang SY, Friedman M, Johnson RG, Weintraub RM, Sellke FW (1994) Adrenergic regulation of coronary microcirculation after extracorporeal circulation and crystalloid cardioplegia. Am J Physiol 267:H2462-H2470
47. Wang XH, Chen SF, Jin HM, Hu RM (2009) Differential analyses of angiogenesis and expression of growth factors in micro- and macrovascular endothelial cells of type 2 diabetic rats. Life Sci 84:240-249
48. Wautier JL, Schmidt AM (2004) Protein glycation. Circ Res 95:233-238
49. Weber M, Mohand-Said S, Hicks D, Dreyfus H, Sahel JA (1996) Monosialoganglioside GM1 reduces ischemia-reperfusion-induced injury in the rat retina. Invest Ophthalmol Vis Sci 37:267-273
50. West DC, Kumar S (1988) Endothelial cell proliferation and diabetic retinopathy. Lancet 1:715-716 (Pubitemid 18083311)
51. Witek B, Król T, Kołataj A, Ochwanowska E, Stanisławska I, Slewa A (2001) The insulin, glucose and cholesterol level and activity of lysosomal enzymes in the course of the model alloxan diabetes. Neuro Endocrinol Lett 22(4):238-242 (Pubitemid 32825457)
52. Yamagishi S, Nakamura K, Imaizumi T (2005) Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diab Rev 1(1):93-106
53. Yan HD, Li XZ, Xie JM, Li M (2007) Effects of advanced glycation end products on renal fibrosis and oxidative stress in cultured NRK-49F cells. Chin Med J (Engl) 120(9):787-793
54. Yang HT, Yan Z, Abraham JA, Terjung RL (2001) VEGF121- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production. Am J Physiol Heart Circ Physiol 280:H1097-H1104
55. Yang HT (2007) Effect of aging on angiogenesis and arteriogenesis. Curr Cardiol Rev 3:65-74
56. Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF beta and promotes tumor invasion and angiogenesis. Genes Dev 14:163-176 (Pubitemid 30070982)
57. Zargar AH, Shah NA, Masoodi SR, Masoodi SR, Laway BA, Wani AI, Dar FA (1998) Copper, zinc and magnesium levels in non insulin dependent diabetes mellitus. Postgrad Med J 74:665-668 (Pubitemid 28508483)
58. Zhang Y, Li J, Partovian C, Sellke FW, Simons M (2003) Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo. Am J Physiol Heart Circ Physiol 284: H2078-H2082 (Pubitemid 36622418)
59. Zimering MB, Andersonc RJ, Luoc P, Moritz TE (2008) Plasma basic fibroblast growth factor is correlated with plasminogen activator inhibitor-1 concentration in adults from the Veterans Affairs Diabetes Trial. Metab Clin Exp 57:1563-1569